Medication continuity is one of the fastest ways housing instability turns into avoidable harm. Many plans assume secure storage, refrigeration, regular meals, and predictable pharmacy accessâconditions that often do not exist. This article sits within Housing Instability & Care Access and links directly to Health Inequities & Access Barriers because medication failure is frequently an access barrier expressed as clinical deterioration, not ânonadherence.â
The operational goal is to make medication safety deliverable under instability: build realistic access routes, remove predictable storage barriers, and implement adherence support that is auditable and proportionate to risk.
Why Medication Plans Fail Under Housing Instability
When housing is unstable, medication failure is rarely a single event. It is usually a predictable chain: prescriptions are issued but not filled, medications are lost or stolen, doses are skipped due to food insecurity or side effects, and follow-up is missed because contact is unreliable. These failures then present as ED visits, worsening chronic conditions, mental health crisis, or infection complications.
Services that treat this as individual behavior miss the system reality. A defensible model builds medication continuity as a workflow: access, storage, reconciliation, and follow-up ownership.
Operational Example 1: A âMedication Access Planâ at Point of Prescribing (Not After the Problem Appears)
What happens in day-to-day delivery
When medication is prescribed or changed, staff complete a short âaccess planâ that becomes part of the care plan: where the prescription will be filled, how the person will get there, what identification or coverage barriers exist, and whether same-day supply is needed. The plan includes a fallback route if the first pharmacy cannot supply (second site, alternate formulary, or a partner dispensing point where locally available). The prescriber or care coordinator documents the chosen route and assigns a named role to confirm fill completion within a defined window (often 24â48 hours for higher-risk medications). If contact is unreliable, confirmation uses place-based channels already agreed in the personâs reachability plan (e.g., a partner site message asking the person to check in).
Why the practice exists (failure mode it addresses)
This exists to prevent the common breakdown where a prescription is written, recorded as âdone,â and the system assumes access will happen. It addresses the failure mode of unfilled prescriptions, delayed starts, and rapid symptom return because the âfillâ step was never operationally owned.
What goes wrong if it is absent
Without a medication access plan, teams discover gaps only when the person deteriorates or re-presents in crisis. Staff may repeatedly âreissueâ prescriptions without solving the underlying access barrier. The record then shows activity (multiple prescriptions) but not continuity (no confirmation of fill or start), which weakens accountability and learning.
What observable outcome it produces
Services can measure fill-confirmation rates, time-to-start for new medications, and the proportion of medication changes with a documented access route and fallback. These metrics link directly to reduced avoidable ED visits and fewer medication-related incidents.
Operational Example 2: Storage and Handling Controls (Including Cold Chain) That Match Real Living Conditions
What happens in day-to-day delivery
Teams assess whether the person can store medications safely (theft risk, exposure to heat/cold, privacy risk) and whether any medications require refrigeration. Where storage is unsafe, the service implements practical options: smaller dispense quantities with more frequent pickup, secure storage at a trusted partner site with agreed access rules, or supervised administration for higher-risk regimens when feasible. For cold-chain needs, staff identify a viable solution before prescribing where possible (alternate medication that does not require refrigeration, partner-site refrigeration with controlled access, or clinically justified step-down arrangements during acute phases). All chosen controls are documented with who holds responsibility and what the person can realistically do.
Why the practice exists (failure mode it addresses)
This exists because âsafe storageâ is a hidden dependency. It addresses the failure mode where medications are lost, stolen, degraded by temperature, or avoided because taking them publicly is unsafe, leading to preventable deterioration and crisis use.
What goes wrong if it is absent
Without storage controls, even motivated patients cannot maintain continuity. Insulin may be spoiled, inhalers lost, antibiotics interrupted, and psychiatric medications stopped abruptly due to theft or instability. The system then labels the outcome as adherence failure rather than a predictable design gap, and harm repeats across cycles of discharge and re-presentation.
What observable outcome it produces
Services can track medication loss reports, replacement frequency, cold-chain breaches (or proxy indicators), and the rate of regimen interruptions. Audit can confirm that storage risks were assessed and that a matched control was implemented rather than ignored.
Operational Example 3: Adherence Support That Is Proportionate, Non-Punitive, and Evidence-Based
What happens in day-to-day delivery
The team stratifies adherence risk based on medication type and clinical risk (e.g., anticoagulants, insulin, seizure meds, complex psychiatric regimens). For higher-risk cases, staff use structured supports: brief dosing education tied to real routines (âwhere will you be at the time you take this?â), simplified regimens where clinically appropriate, and scheduled check-ins that do not rely on a single phone call (drop-in windows, outreach touchpoints, or partner-site check-ins). The service documents a minimum adherence-support bundle (what was taught, how understanding was checked, and how follow-up will occur). If side effects or food insecurity make dosing unsafe, the plan includes explicit instructions for what to do and who to contact.
Why the practice exists (failure mode it addresses)
This exists to prevent the failure mode where adherence advice is generic and detached from reality. It addresses the risk pattern of missed doses, unsafe self-adjustment, abrupt discontinuation, and side-effect-driven disengagementâcommon triggers of ED use and clinical destabilization.
What goes wrong if it is absent
Without proportionate support, teams either over-assume capacity (âjust take as directedâ) or respond punitively when doses are missed. The person may stop medications due to side effects or because dosing is incompatible with their daily survival tasks. Deterioration then presents as âmysteryâ relapse, avoidable crisis, or medication harm that could have been prevented through realistic planning.
What observable outcome it produces
Services can track adherence-support bundle completion, medication-related ED visits, crisis events linked to regimen interruption, and stabilization indicators (fewer urgent contacts, improved symptom control, fewer replacement prescriptions). Governance can review whether high-risk medications consistently trigger higher-intensity support.
Two Oversight Expectations for Medication Continuity Under Housing Instability
Expectation 1: Documented reconciliation and responsibility when medications change.
Oversight bodies and funders commonly expect that medication changes are reconciled with a clear owner for follow-up. A defensible record shows what changed, why, how access will occur, and how the service confirmed the person could start and continue safely.
Expectation 2: Risk-proportionate controls for high-risk regimens (not one-size-fits-all).
Systems are expected to demonstrate that higher-risk medications trigger enhanced safeguardsâmore frequent follow-up, storage solutions, or supervised support where appropriateârather than relying on generic instructions that predictably fail under instability.
Governance and Assurance: Keeping the Model Auditable
Medication continuity becomes reliable when it is governed like other safety-critical processes: standard access planning at prescribing, storage risk assessment, and risk-based adherence support. Simple audits (sampled monthly) can confirm whether access plans were documented, fill completion was confirmed, and storage controls were matched to riskâturning a common failure point into a measurable continuity pathway.